Engage With the Global Community of Senior TCR Experts
Are you committed to supporting the development and commercialization of TCR-based cell and biologic therapies?
The 7th TCR-Based Therapies Summit is your gateway to connect with the most influential minds across the TCR ecosystem, at a defining moment for the field. With clinical validation now established, attention has now shifted towards the factors that will determine long-term success: scalable manufacturing, durable responses, broader patient reach, and sustainable commercial models.
If your solutions support critical needs across TCR discovery and sequencing, HLA typing, immune profiling, companion diagnostics, preclinical models, or manufacturing optimization, this summit offers you direct access to a highly curated group of senior biopharma and academic experts, all actively evaluating partners to advance their pipelines.
Ready to align your brand with an intimate, high-level audience shaping the future of TCR-based therapies? Let’s explore the bespoke partnership opportunities available for your specific strategic and commercial goals.
The Value You Will Gain as a Partner
Position Yourself as a Leading TCR Solution Provider
Showcase your expertise to a highly targeted audience of senior decision-makers actively seeking strategic and technical partners to overcome key discovery, engineering, and manufacturing challenges.
Build Meaningful Connections with TCR Pioneers
Take advantage of extensive networking opportunities with C-suite executives, senior scientists, and development leaders from biotech, pharma, and academia shaping the future direction of TCR-based cell and biologic therapies.
Stay at the Forefront of TCR Innovation
Gain first-hand insight from industry leaders advancing the next-generation of TCR-based therapies to understand evolving hurdles in target selection, durability, scalability, and commercial viability, so you can position yourself as a true scientific partner.
Boost Your Brand Visibility & Credibility
Leverage high-impact branding opportunities and share your capabilities across TCR discovery, HLA typing, immune screening, companion diagnostics, and preclinical model provision to leave a lasting impression on the leaders driving TCR innovation forward.
Key Interest Areas
Our audience of TCR developers are looking for service and solution providers with capabilities in the below areas but not limited to:
TCR Discovery & Sequencing
HLA Testing/Typing & Immunohistochemistry (IHC)/Immune Screening
Biomarker & Companion Diagnostics
CROs & Model Providers
Hear What Our Past Sponsors Have to Say
This meeting offered great insights into the cutting-edge technology and drug development advances happening in the TCR field
Associate Director, Business Development, Alloy Therapeutics, 2026 Partner
A good opportunity to connect with companies in the TCR space, as well as the chance to learn more about different approaches and technologies
Associate Director, Sales, Made Scientific, Past Partner
The attendees were exceptionally open for discussion, very chatty and friendly, and the program was highly interesting and focused
Flow Cytometry Reagents & Global Product Manager, Miltenyi Biotec, 2026 Partner
The room boasted a great mix of people, including experienced leaders and established industry players
Chief Scientific Officer, Alithea Biotechnology, Past Partner
Audience Composition
Company Type
Attendee Seniority
Statistics Taken from the 6th TCR-Based Therapies Summit
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as badges, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Kieran Crewe
Senior Business Development Manager